Inventor · disambiguated record
Jürgen Hausmann
Also filed as: HAUSMANN JUERGEN · HAUSMANN JÜRGEN · HAUSMANN JÜRGEN HAUSMANN
8 granted patents·5 pending applications·29 citations·filing 2010–2022
81Inventor score
Top patents by PatentIndex Score
13 records- 0185US8613936B2Replication deficient recombinant viruses expressing antigens regulated by transcriptional control elements comprising multiple elementsHAUSMANN JUERGEN·Filed 2011·Granted Dec 24, 2013·9 cites·17 claims
- 0281US8394385B2Optimized early-late promoter combined with repeated vaccination favors cytotoxic T cell response against recombinant antigen in MVA vaccinesHAUSMANN JUERGEN·Filed 2010·Granted Mar 12, 2013·14 cites·16 claims
- 0380US8883168B2Modulation of immune responses by the poxviral K4 proteinHAUSMANN JÜRGEN·Filed 2011·Granted Nov 11, 2014·4 cites·28 claims
- 0476US9163237B2Replication deficient recombinant viruses expressing antigens regulated by transcriptional control elements comprising multiple elementsBAVARIAN NORDIC AS·Filed 2013·Granted Oct 20, 2015·2 cites·11 claims
- 0558US11338030B2Multivalent recombinant modified vaccinia virus ankara (MVA) vector encoding filovirus immunogensBAVARIAN NORDIC AS·Filed 2020·Granted May 24, 2022·0 cites·12 claims
- 0658US2024392257A1Utilization of Micro-RNA for Downregulation of Cytotoxic Transgene Expression by Modified Vaccinia Virus Ankara (MVA)BAVARIAN NORDIC AS·Filed 2022·Application pending·0 cites
- 0754US2020325477A1Compositions and Methods for Inducing an Enhanced Immune Response Using Poxvirus VectorsBAVARIAN NORDIC AS·Filed 2020·Application pending·0 cites
- 0851US2016376596A1Compositions and methods for inducing an enhanced immune response using poxvirus vectorsBAVARIAN NORDIC AS·Filed 2014·Application pending·0 cites
- 0950US2023233670A1A Recombinant Modified Vaccinia Virus (MVA) Vaccine Against Coronavirus DiseaseBAVARIAN NORDIC AS·Filed 2021·Application pending·0 cites
- 1046US10576141B2Recombinant modified vaccinia virus Ankara (MVA) multivalent filovirus immunogenic compositions and methods of useBAVARIAN NORDIC AS·Filed 2015·Granted Mar 3, 2020·0 cites·12 claims
- 1146US2023190922A1Recombinant MVA Viruses for Intratumoral and/or Intravenous Administration for Treating CancerBAVARIAN NORDIC AS·Filed 2020·Application pending·0 cites
- 1245US8859257B2Vaccinia virus mutants containing the major genomic deletions of MVAHAUSMANN JÜRGEN·Filed 2011·Granted Oct 14, 2014·0 cites·23 claims
- 1341US9173933B2Recombinant modified vaccinia virus Ankara influenza vaccineWEIGL JOSEF·Filed 2011·Granted Nov 3, 2015·0 cites·20 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →